How to run an ambient scribe pilot, and what to actually measure

You have seen the demo. The note was good, the room liked it, and the clinicians who watched are willing to try it. So the question is no longer “is this impressive”. It is the harder one: how do I prove this works for my clinicians, in my workflow, before I commit to a rollout?

A pilot is the right tool for that question, but only if you design it to produce evidence instead of a feeling. Run it loosely and you will end up with a few enthusiastic quotes and no idea whether the thing actually moved a number. Run it well and you replace every vendor’s marketing claim with your own data. This is the same vendor-neutral lens we brought to EHR integration questions: the points below apply to any scribe on your shortlist, ours included.

Decide what success looks like before you start

Write down two or three testable target outcomes before go-live, each with a direction and a rough threshold, and get clinical, IT, and revenue-cycle stakeholders to agree on them in advance. Something like: after-hours charting trends down for the pilot cohort; same-day note closure improves; clinician-reported documentation burden drops on a short survey. The numbers themselves matter less than the agreement. The point is that when the readout lands, nobody gets to relitigate what “success” meant because the survey looked soft or the time data looked too good.

No honest vendor will promise you a guaranteed figure, and you should be wary of one that does. These targets are not a contract. They are a shared yardstick you set yourselves, so the decision at the end is about the evidence and not about whose interpretation wins the meeting.

Choose a representative cohort and a long enough run

Pick a cohort that looks like the rollout you are actually contemplating, not the easiest possible test. Mix specialties and visit types, mix levels of EHR comfort, and deliberately include at least one skeptic. A pilot staffed only by volunteers who already love the idea tells you how the tool performs for people who love the idea, which is not the question.

Make it large enough that one person having a strange week cannot swing the result. And separate the learning curve from the steady state: people are slower and clumsier in their first days with any new tool, so measure a ramp-up period on its own and judge the technology on the weeks after it. There is no universally correct length, but the run should cover enough normal clinic weeks that what you see is behaviour, not novelty. Short pilots flatter new tools.

Baseline before you turn anything on

You cannot measure improvement without a “before”. Capture the same metrics, for the same clinicians, before go-live. Wherever you can, take those numbers from EHR event-log data rather than from people’s recollection.

Self-reported before-and-after estimates drift, usually in the flattering direction, because everyone remembers the bad old days as worse than they were. System data does not have an opinion. For the things you genuinely cannot measure from logs, like perceived burden or cognitive load, use a short validated survey and run the identical instrument at both ends so the two readings are comparable. Baseline first, or you are guessing.

The metrics that actually matter

Treat all of these as signals to watch over the pilot, not guarantees.

Clinician-side

• Documentation time per note. Pull it from EHR logs, not stopwatches. This is the core efficiency signal.
• After-hours and “pajama-time” charting. The burnout lever. If work is following clinicians home, this is where you will see it move, and where it matters most for clinician wellbeing.
• Note turnaround and same-day closure. Faster, cleaner closure means the documentation debt is not just being deferred.
• Clinician edit and acceptance rate on drafts. The honest draft-quality signal. If clinicians are heavily rewriting every note, the tool is not saving the time it appears to: the work just moved into editing.
• Clinician experience. A short validated instrument at both ends beats a hallway “do you like it?”.

Org-side

• Coding accuracy and clean-claim signals. Documentation is the front-end act where denials start. Watch clean-claim or first-pass rate. Do not let anyone promise a denial-reduction percentage, including a vendor citing AI coding accuracy.
• EHR write-back success. A note that does not reliably land as structured data is a copy-paste chore wearing a nicer interface. Measure how often write-back actually succeeds in your system, which is exactly the integration question the demo glosses over.

Peer-reviewed frameworks now exist for evaluating ambient scribes across several dimensions at once, which is a useful reminder that a single headline number rarely captures the whole picture.

The vanity metrics that flatter a pilot

Some numbers look like results and are not. Watch for these:

• Raw minutes “saved” with no baseline. Saved compared to what? Without a before, this is a number you invented.
• Notes generated or usage counts. That is activity, not benefit. A busy tool is not a useful one.
• Satisfaction from a self-selected volunteer group. They were always going to be happy. That is selection bias, not evidence.
• Time-in-note dropping while edit time quietly rises. The work moved; it did not disappear. Read those two together or not at all.
• A clean-claim rate over too few claims. Small denominators produce big, meaningless swings.

The pattern is simple: be suspicious of anything that goes up just because people used the tool more, rather than because people are actually better off.

What a pilot can and cannot tell you

A scribe is one lever among many. Inbox burden, prior-auth load, panel size, and staffing all move the same numbers, so a clean result is rarely the scribe acting alone. Confounders are everywhere: a new note template, a staffing change, even seasonality can shift your metrics during the pilot window. Small cohorts give you directional evidence, not statistical proof, and that is fine as long as you call it what it is.

Revenue metrics are the trickiest, because claims move on payer timelines. A short pilot may simply end before the full clean-claim picture resolves. No vendor, us included, can promise you a specific percentage on any of this. What a well-run pilot does is replace those promises with your own evidence, which is worth far more.

How we think about it

We would genuinely rather you run a rigorous pilot, with a real baseline and a yardstick you set, than take any vendor’s headline number on faith, ours included. A good pilot is designed so that it could fail. That is precisely what makes a pass mean something.

Through all of it, the human stays the gate. The clinician reviews and approves the note and the codes before anything is final, which is also what keeps the edit-and-acceptance metric honest: it measures real review, not rubber-stamping.

If you are scoping a pilot, see the platform page or talk to us, and hold us to your own metrics.